This study tested the safety of a new imaging agent called NH002, which is injected to help ultrasound machines get clearer pictures of the heart. It involved 36 adults with suspected heart disease to see how their bodies reacted to different doses. The main goal was to check for…
Phase: PHASE1, PHASE2 • Sponsor: Trust Bio-sonics, Inc. • Aim: Diagnosis
Last updated Mar 23, 2026 15:15 UTC